Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care... see more

Bullboard (TSXV:COV)

View:
Post by Possibleidiot01on May 01, 2024 7:10am

Mathieu Martin Oct 20, 2023

Covalon Technologies (TSX-V: COV) https://stocksandstones.substack.com/p/flurry-of-acquisitions Covalon is a medical device company in the wound care space. They already ran a strategic ...more  
Comment by ARIMA11on Feb 02, 2024 5:45pm

RE:Impressive looking financial results

Still... Net Loss of (4.4M) in FY2023 and (2.8M) in Q4 2023.  Also from 22.9M in cash Q4 2021 to 8.79M in Q4 2023. Bottom line is the bottom line need to increase. How much more cash burn to be ...more  
Post by bronkrdron Jan 29, 2024 1:33pm

Impressive looking financial results

Revenue for the year ended September 30, 2023 increased 47% to $26.6M compared to $18.1M for the same period of the prior year. Product revenue for the year ended September 30, 2023 increased 46% to ...more  
Comment by ARIMA11on Jan 05, 2024 11:10am

RE:new CEO

Ok. Now we're talkin. Sustainability and Profitability. Also compensation is aligned with shareolders. Great addition (an outsider) which was much needed here. Let's see how it goes.
Post by Possibleidiot01on Jan 04, 2024 7:37am

new CEO

Exercise price 20% above current price. Seems very well qualified. Mr. Ashton will be granted 800,000 stock options that will vest equally over four years at an exercise price equal to the greater ...more  
Post by tiker22on Dec 01, 2023 1:57pm

RBC rating

On RBC's list of promising small caps.
Comment by ARIMA11on Nov 14, 2023 9:39am

RE:RE:Leadership changes

Let's hope these guys wake up soon. Best thing they can do is sell the company. After years of talking, cash burn, the stock price speaks for itself.
Comment by Possibleidiot01on Sep 29, 2023 11:59am

RE:RE:Leadership changes

Seems like no ill will here as he remains on the board ; could be a mutual thing as it appears there is value here to be unlocked
Comment by nkbourbakion Sep 26, 2023 10:05am

RE:Leadership changes

Can't see this being planned, as it is effective immediately without a replacement in mind.  Even without knowing the replacement I'd say this is a positive development.  At list it ...more  
Post by Possibleidiot01on Sep 26, 2023 8:18am

Leadership changes

Brian Pedlar, who will remain on Covalon’s Board of Directors. Also has a comment from a major shareholder and board member "“As an experienced CEO, and member of Covalon’s Board since 2020 ...more  
Post by LTNvestoron Sep 25, 2023 10:19am

Life with a Central Line [WEBINAR] - Link to PR 9.23.23

https://ir.covalon.com/news/news-details/2023/Life-with-a-Central-Line-WEBINAR-Key-Considerations-from-the-Patients-Perspective/default.aspx
Comment by ARIMA11on Aug 16, 2023 11:18am

RE:RE:Interesting

Let's see if they do it. They certainly have not continued it since it expired... https://ir.covalon.com/news/news-details/2022/COVALON-TECHNOLOGIES-LTD.-ANNOUNCES-NORMAL-COURSE-ISSUER-BID-05-25 ...more  
Comment by mcapproon Aug 16, 2023 11:18am

RE:RE:RE:Interesting

That doesn't mean they need to raise money.  
Comment by ARIMA11on Aug 16, 2023 11:13am

RE:RE:Interesting

Look at the cash balance on a quarterly basis.... It's not going up... :)
Comment by mcapproon Aug 16, 2023 10:46am

RE:Interesting

Where are they using $2-$3M per quarter?  The recent annual performance shows just over $1.1M in Adjusted EBITDA loss (cash burn) for the 9 months for fiscal 2023.  The company has a strong ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities